Stay updated with breaking news from Dan Manea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (NASDAQ:PODD – Free Report) had its price target cut by Bank of America from $365.00 to $295.00 in a research report report published on Thursday, MarketBeat.com reports. They currently have a buy rating on the medical instruments supplier’s stock. Other equities research analysts also recently issued reports about the stock. Raymond James reduced their […]
Bessemer Group Inc. boosted its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 37.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 315 shares of the medical instruments supplier’s stock after purchasing an additional 85 shares during […]
Citigroup upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a neutral rating to a buy rating in a report released on Monday, Marketbeat Ratings reports. They currently have $265.00 price target on the medical instruments supplier’s stock, down from their previous price target of $273.00. A number of other brokerages also recently commented on […]
Equities researchers at StockNews.com began coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the medical instruments supplier’s stock. A number of other brokerages have also commented on PODD. Wells Fargo & Company cut their price target on Insulet […]
California State Teachers Retirement System lowered its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 0.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,611 shares of the medical instruments supplier’s stock after selling 1,045 shares during the […]